Neurobiological findings in bipolar II disorder compared with findings in bipolar I disorder

Canadian Journal of Psychiatry

Volumn 49, Issue 12, 2004, Pages 794-801

  McGrath, Brent M ^a   Wessels, Phillip H ^a   Bell, Emily C ^a   Ulrich, Michele ^a   Silverstone, Peter H ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Bipolar disorder subtypes; Calcium; Genetics; Imaging; Metabolism

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; CALCIUM; CHOLINE DERIVATIVE; INOSITOL; N ACETYLASPARTIC ACID; PROTEIN KINASE C;

BIPOLAR I DISORDER; BIPOLAR II DISORDER; BRAIN METABOLISM; CALCIUM CELL LEVEL; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ANALYSIS; HUMAN; MEDICAL LITERATURE; NEUROBIOLOGY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 12744278192     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370404901202     Document Type: Review

References (85)

1. McElroy SL, Keck PE Jr, Strakowski SM. Mania, psychosis and antipsychotics. J Clin Psychiatry 1996;57:14-26.
2. Dunner DL, Dwyer T, Fieve RR. Depressive symptoms in patients with unipolar and bipolar affective disorder. Compr Psychiatry 1976;17:447-51.
3. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, and others. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity survey. Arch Gen Psychiatry 1994;51(1):8-19.
4. Kelsoe JR. Arguments for the genetic basis of the bipolar spectrum. J Affect Disord 2003;73:183-97.
5. Merikangas KR, Chakravarti A, Moldin SO, Araj H, Blangero JC, Burmeister M, and others. Future of genetics of mood disorders research. Compr Psychiatry 2002;52:457-7.
6. Kendler KS, Pedersen N, Johnson L, Neale MC, Mathe AA. A pilot Swedish twin study of affective illness, including hospital- and population-ascertained subsamples. Arch Gen Psychiatry 1993;50:699-700.
7. Gershon E, Hamovit J, Guroff JJ, Dibble E, Leckman JF, Sceery W, and others. A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry 1982;39:1157-67.
8. Detera-Wadleigh SD, Badner JA, Berrettini WH, Yoshikawa T, Goldin LR, Turner G, and others. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc Natl Acad Sci USA 1999;96:5604-9.
9. Heun R, Maier W. The distinction of bipolar II disorder from bipolar I and recurrent unipolar depression: results of a controlled family study. Acta Psychiatr Scand 1993;87:279-84.
10. Benazzi F. Bipolar II disorder family history using the family history screen: findings and clinical implications. Compr Psychiatry 2004;45(2):77-82.
11. Sadovnick AD, Remick RA, Lam R, Zis AP, Yee IML, Huggins MJ, and others. Mood disorder service genetic database; morbidity risks for mood disorders in 3,942 first-degree relatives of 671 index cases with single depression, recurrent depression, bipolar I, or bipolar II. Am J Med Genet 1994;54:132-40.
12. Chen HH, Nicoletti MA, Hatch JP, Sassi RB, Axelson D, Brambilla P, and others. Abnormal left superior temporal gyrus volumes in children and adolescents with bipolar disorder: a magnetic resonance imaging study. Neurosci Lett 2004;363:65-8.
13. DelBello MP, Zimmerman ME, Mills NP, Getz GE, Strakowski SM. Magnetic resonance imaging analysis of amygdale and other subcortical brain regions in adolescents with bipolar disorder. Bipolar Disord 2004;6:43-52.
14. Brambilla P, Nicoletti M, Sassi RB, Mallinger AG, Frank E, Keshavan MS, and others. Corpus callosum signal intensity in patients with bipolar and unipolar disorder. J Neurol Neurosurg Psychiatry 2004;75:221-5.
15. Adler CM, Holland SK, Schmithorst V, Wilke M, Weiss KL, Pan H, and others. Abnormal frontal white matter tracts in bipolar disorder: a diffusion tensor imaging study. Bipolar Disord 2004;6:197-203.
16. Kasai K, Shenton ME, Salisbury DF, Onitsuka T, Toner SK, Yurgelun-Todd D, and others. Differences and similarities in insular and temporal pole MRI gray matter volume abnormalities in first-episode schizophrenia and affective psychosis. Arch Gen Psychiatry 2003;60:1069-77.
17. Brambilla P, Nicoletti MA, Harenski K, Sassi RB, Mallinger AG, Frank E, and others. Anatomical MRI study of subgenual prefrontal cortex in bipolar and unipolar subjects. Neuropsychopharmacol 2002;27:792-9.
18. Sassi RB, Nicoletti M, Brambilla P, Harenski K, Mallinger AG, Frank E, and others. Decreased pituitary volume in patients with bipolar disorder. Biol Psychiatry 2001;50:271-80.
19. Videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr Scand 2000;101:11-20.
20. Gyulai L, Alavi A, Broich K, Reilley J, Ball WB, Whybrow PC. I-123 iofetamine single-photon computed emission tomography in rapid cycling bipolar disorder: a clinical study. Biol Psychiatry 1997;41:152-61.
21. Rubinsztein JS, Fletcher PC, Rogers RD, Ho LW, Aigbirhio FI, Paykel ES, and others. Decision-making in mania: a PET study. Brain 2001;124:2550-63.
22. Bonne O, Krausz Y, Gorfine M, Karger H, Gelfin Y, Shapira B, and others. Cerebral hypoperfusion in medication resistant, depressed patients assessed by Tc99m HMPAO SPECT. J Affect Disord 1996;41:163-71.
23. Drevets WC, Price JL, Simpson Jr JR, Todd RD, Reich T, Vannier M, and others. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997;386:824-7.
24. Ito H, Kawashima R, Awata S, Ono S, Sato K, Goto R, and others. Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique. J Nucl Med 1996;37:410-4.
25. Ketter TA, Kimbrell TA, George MS, Dunn RT, Speer AM, Benson BE, and others. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry 2001;49:97-109.
26. Baxter LR, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, and others. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989;46:243-50.
27. Lawrence NS, Williams AM, Surguladze S, Giampietro V, Brammer MJ, Andrew C, and others. Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression. Biol Psychiatry 2004;55:578-87.
28. Caligiuri MP, Brown GG, Meloy MJ, Eyler LT, Kindermann SS, Eberson S, and others. A functional magnetic resonance imaging study of cortical asymmetry in bipolar disorder. Bipolar Disord 2004;6:183-96.
29. Curtis VA, Dixon TA, Morris RG, Bullmore ET, Brammer MJ, Williams SC, and others. Differential frontal activation in schizophrenia and bipolar illness during verbal fluency. J Affect Disord 2001;66:111-21.
30. Malhi GS, Lagopoulos J, Ward PB, Kumari V, Mitchell PB, Parker GB, and others. Cognitive generation of affect in bipolar depression: an fMRI study. Eur J Neurosci 2004;19:741-54.
31. Strakowski SM, Adler CM, Holland SK, Mills N, DelBello MP. A preliminary fMRI study of sustained attention in euthymic, unmedicated bipolar disorder. Neuropsychopharmacol 2004;29:1734-40.
32. Malhi GS, Lagopoulos J, Sachdev P, Mitchell PB, Ivanovski B, Parker GB. Cognitive generation of affect in hypomania: an fMRI study. Bipolar Disord 2004;6:271-85.
33. Blumberg HP, Leung H-C, Skudlarski P, Lacadie CM, Fredricks CA, Harris BC, and others. A functional magnetic resonance imaging study of bipolar disorder. state- and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry 2003;60:601-9.
34. Majerus PW, Connolly TM, Bansal VS, Inhorn RC, Ross TS, Lips DL. Inositol phosphates: synthesis and degradation. J Biol Chem 1988;263:3051-4.
35. Berridge MJ, Downes CP, Hanley MR. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J 1982;206:587-95.
36. Moore GJ, Bebchuk JM, Parrish JK, Faulk MW, Arfken CL, Strahl-Bevacqua J, and others. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am J Psychiatry 1999;156:1902-8.
37. Kato T, Shioiri T, Murashita J, Hamakawa H, Takahashi Y, Inubushi T, and others. Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Psychol Med 1995;25:557-66.
38. Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK, and others. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 2004;61:450-8.
39. Davanzo P, Yue K, Thomas MA, Belin T, Mintz J, Venkatraman TN, and others. Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents. Am J Psychiatry 2003;160:1442-52.
40. Silverstone PH, Wu RH, O'Donnell T, Ulrich M, Asghar SJ, Hanstock CC. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients. Human Psychopharmacol 2002;17:321-7.
41. Deicken RF, Weiner MW, Fein G. Decreased temporal lobe phosphomonoesters in bipolar disorder. J Affect Disord 1995;33:195-9.
42. Kato T, Takahashi S, Shioiri T, Murashita J, Hamakawa H, Inubushi T. Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord 1994;31:125-33.
43. Tondo L, Baldessarini RJ, Hennen J, Floris G. Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am J Psychiatry 1998;155:638-45.
44. Malhi GS, Valenzuela M, Wen W, Sachidev P. Magnetic resonance spectroscopy and its applications in psychiatry. Aust N Z J Psychiatry 2002;36:31-43.
45. Tsai G, Coyle JT. N-Acetylaspartate in neuropsychiatric disorders. Prog Neurobiol 1995;46:531-40.
46. Chang K, Adleman N, Dienes K, Barnea-Goraly N, Reiss A, Ketter T. Decreased N-acetylaspartate in children and familial bipolar disorder. Biol Psychiatry 2003;53:1059-65.
47. Winsberg ME, Sachs N, Tate DL, Adalsteinsson E, Spielman D, Ketter TA. Decreased dorsolateral prefrontal N-acetylaspartate in bipolar disorder. Biol Psychiatry 2000;47:475-81.
48. Bertolino A, Frye M, Callicott JH, Mattay VS, Rakow R, Shelton-Repella J, and others. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 2003;53:906-13.
49. Hamakawa H, Kato T, Murashita J, Kato N. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. Eur Arch Psychiatr Clin Neurosci 1998;248:53-8.
50. Duc CO, Weber Ah, Trabesinger AH, Meier D, Boesiger P. Recycling the cholines. [proceedings of the International Society of Magnetic Resonance in Medicine] 1997;6:1210.
51. Gupta RK, Bhatia V, Poptani H, Gujral RB. Brain metabolic changes on in vivo proton magnetic resonance spectroscopy in children with congenital hypothyroidism. J Pediatr 1995;126:389-92.
52. Silverstone PH, Asghar SJ, O'Donnell T, Ulrich M, Hanstock CC. Lithium and valproate protect against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients. World J Biol Psychiatry 2004;5:38-44.
53. Davanzo P, Thomas MA, Yue K, Oshiro T, Belin T, Strober M, and others. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacol 2001;24:359-69.
54. Castillo M, Kwock L, Courvoisie H, Hooper SR. Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations. AJNR Am J Neuroradiol 2000;21:832-8.
55. Ohara K, Isoda H, Suzuki Y, Takehara Y, Ochiai M, Takeda H, and others. Proton magnetic resonance spectroscopy of the lenticular nuclei in bipolar I affective disorder. Psychiatry Res 1998;84(2-3):55-60.
56. Kato T, Hamakawa H, Shioiri T, Murashita J, Takahashi Y, Takahashi S, Inubushi T. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. J Psychiatry Neurosci 1996;21:248-54.
57. Dubovsky SL, Franks RD. Intracellular calcium ions in affective disorders: a review and a hypothesis. Biol Psychiatry 1983;18:781-97.
58. Emamghoreishi M, Schlichter L, Li PP, Parikh S, Sen J, Kamble A, Warsh JJ. High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder. Am J Psychiatry 1997;154:976-82.
59. Berk M, Bodemer W, van Oudenhove T, Butkow N. Dopamine increases platelet intracellular calcium in bipolar affective disorder and control subjects. Int Clin Psychopharmacol 1994;9:291-3.
60. Wasserman MJ, Corson TW, Sibony D, Cooke RG, Parikh SV, Pennefather PS, and others. Chronic lithium treatment attenuates intracellular calcium mobilization. Neuropsychopharmacol 2004;29:759-69.
61. Dubovsky SL, Christiano J, Daniell LC, Franks RD, Murphy J, Adler L, and others. Increased platelet intracellular calcium concentration in patients with bipolar affective disorder. Arch Gen Psychiatry 1989;46:632-8.
62. Eckert A, Gann H, Riemann D, Aldenhoff J, Muller WE. Platelet and lymphocyte free intracellular calcium in affective disorders. Eur Arch Psychiatry Clin Neurosci 1994;243:235-9.
63. Kato T, Ishiwata M, Mori K, Washizuka S, Tajima O, Akiyama T, and others. Mechanisms of altered Ca2+ signaling in transformed lymphoblastoid cells from patients with bipolar disorder. Int J Neuropsychopharmacol 2003;6:379-89.
64. Yamawaki S, Kagaya A, Tawara Y, Inagaki M. Extracellular calcium signaling systems in the pathophysiology of affective disorders. Life Sci 1998;62:1665-70.
65. Berk M, Bodemer W, van Oudenhove T, Butkow N. The platelet intracellular calcium response to serotonin is augmented in bipolar manic and depressed patients. Hum Psychopharmacol 1995;10:189-93.
66. El Khoury A, Petterson U, Kallner G, Aberg-Wistedt A, Stain-Malmgren R. Calcium homeostasis in long-term lithium-treated women with bipolar affective disorder. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:1063-9.
67. Hough C, Lu S-J, Davis CL, Chuang D-M, Post RM. Elevated basal and thapsigargin-stimulated intracellular calcium of platelets and lymphocytes from bipolar affective disorder patients measured by a fluorometric microassay. Biol Psychiatry 1999;46:247-55.
68. Redmond AM, Leonard BE. An evaluation of the role of the noradrenergic system in the neurobiology of depression: a review. Hum Psychopharmacol 1998;12:407-30.
69. Manji HK, Lenox RH. The nature of bipolar disorder. J Clin Psychiatry 2000;61(Suppl 13):42-57.
70. Deleon-Jones F, Maas JW, Dekermenjian H. Urinary catecholamine metabolites during behavioural changes in patients with manic-depressive cycles. Science 1973;179:300-2.
71. Giedke H, Gaertner HJ, Mahal A. Diumal variation of urinary MHPG in unipolar and bipolar depressives. Acta Psychiatr Scand 1982;66:243-53.
72. Schildkraut JJ, Orsulak PJ, Schatzberg AF, Gudeman JE, Cole JO, Rohde WA, and others. Toward a biochemical classification of depressive disorders I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depression. Arch Gen Psychiatry 1978;35:1427-33.
73. Beckmann H, St-Laurent J, Goodwin FK. The effect of lithium on urinary MHPG in unipolar and bipolar depressed patients. Psychopharmacologia 1975;42:277-82.
74. Beckmann H, Goodwin FK. Urinary MHPG in subgroups of depressed patients and normal control subjects. Neuropsychobiology 1980;6:91-100.
75. Grossman F, Potter WZ. Catecholamines in depression: a cumulative study of urinary norepinehrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH. Psychiatry Res 1999;87:21-7.
76. Shiah I-S, Ko H-C, Lee J-F, Lu R-B. Platelet 5-HT and plasma MHPG levels in patients with bipolar I and bipolar II depressions and normal control subjects. J Affect Disord 1999;52:101-10.
77. Berrettini WH, Nurnberger JI Jr, Scheinin M, Seppala T, Linnoila M, Narrow W, and others. Cerebrospinal fluid and plasma monoamines and their metabolites in euthymic bipolar patients. Biol Psychiatry 1985;20:257-69.
78. Young LT, Warsh JJ, Kish SJ, Shannak K, Hornykeiwicz O. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder. Biol Psychiatry 1994;35:121-7.
79. Wang H-Y, Friedman E. Enhanced protein kinase C activity and translocation in bipolar affective disorder brains. Biol Psychiatry 1996;40:568-75.
80. Hrdina P, Faludi G, Li Q, Bendotti C, Tekes K, Sotonyi P, Palkovits P. Growth-associated protein (GAP-43), its mRNA, and protein kinase C (PKC) isoenzymes in brain regions of depressed suicides. Mol Psychiatry 1998;3:411-8.
81. Dean B, Opeskin K, Pavey G, Hill C, Keks N. Changes in protein kinase C and adenylate cyclase in the temporal lobe from subjects with schizophrenia. J Neural Transm 1997;104:1371-81.
82. Wang H-Y, Markowitz P, Levinson D, Undie AS, Friedman E. Increased membrane-associated protein kinase C activity and translocation in blood platelets from bipolar affective disorder patients. J Psychiatric Res 1999;33:171-9.
83. Soares JC, Chen G, Dippold CS, Frank E, Kupfer DJ, Manji HK, and others. Protein kinase C (PKC) platelet isozymes in lithium-treated bipolar disorder patients. Soc Neurosci 24 abstract nr 194.11;1998:503.
84. Pandey GN, Dwivedi Y, Kumari R, Janicak PG. Protein kinase C in platelets of depressed patients. Biol Psychiatry 1998;44:909-11.
85. Pandey GN, Dwivedi Y, SridharaRao J, Ren X, Janicak PG, Sharma R. Protein kinase C and phospholipase C activity and expression of their specific isozymes is decreased and expression of MARCKS is increased in platelets of bipolar but not in unipolar patients. Neuropsychopharmacol 2002;26:216-28.